Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2020Antimicrobial Agents and ChemotherapyOpen Access

Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMiguel Ángel Martı́nez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miguel Ángel Martı́nez (2020) studied this question.

synapsesocial.com/papers/6a90fef89d3e7f78367a6731https://doi.org/10.1128/aac.00399-20
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses2017 · 1,641 citations
  2. 2A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics2019 · 1,664 citations
  3. 3Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV2020 · 1,815 citations
  4. 4Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study2019 · 88 citations